False-negative studies may systematically contaminate the literature on the effects of inducers in neuropsychopharmacology: part II: focus on bipolar disorder.
From the University of Kentucky Mental Health Research Center, Eastern State Hospital, Lexington, KY; and Psychiatry and Neurosciences Research Group (CTS-549), Institute of Neurosciences, University of Granada, Granada, Spain.
Jose
J
de Leon
D018692:Antimanic Agents / Q000378:metabolism / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000378:metabolism / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy*; D004347:Drug Interactions; D004790:Enzyme Induction / Q000187:drug effects*; D005188:False Negative Reactions; D006801:Humans; D012107:Research Design
D018692:Antimanic Agents; D014150:Antipsychotic Agents